Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study-Reference-Cited by-同舟云学术

Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study

Published:2021-06 Issue:9 Volume:30 Page:1153-1161
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Luise Cynthia¹^ORCID,Sugiyama Naonobu²,Morishima Toshitaka³,Higuchi Takakazu⁴,Katayama Kayoko⁵,Nakamura Sho⁶⁷,Chen Haoqian⁸,Nonnenmacher Edward⁸,Hase Ryota⁹¹⁰,Jinno Sadao¹¹,Kinjo Mitsuyo¹²,Suzuki Daisuke¹³,Tanaka Yoshiya¹⁴,Setoguchi Soko⁸¹⁵

Affiliation:

1. Safety Surveillance Research Pfizer Inc New York New York USA

2. Inflammation & Immunology, Medical Affairs Pfizer Japan Tokyo Japan

3. Department of Cancer Strategy, Cancer Control Center Osaka International Cancer Institute Osaka Japan

4. Blood Transfusion Department Dokkyo Medical University Saitama Medical Center Koshigaya Japan

5. Cancer Prevention and Cancer Control Division Kanagawa Cancer Center Research Institute Yokohama Japan

6. School of Health Innovation Kanagawa University of Human Services Yokosuka Japan

7. Department of Clinical Oncology Faculty of Medicine, Yamagata University Yamagata Japan

8. Center for Pharmacoepidemiology and Treatment Science Rutgers Institute for Health, Health Care Policy and Aging Research New Brunswick New Jersey USA

9. Department of Infectious Diseases Kameda Medical Center Kamogawa Japan

10. Department of Infectious Diseases Japanese Red Cross Narita Hospital Narita Japan

11. Section of Rheumatology Kobe University School of Medicine Kobe Japan

12. Division of Rheumatology Okinawa Chubu Hospital Uruma Japan

13. Department of Infectious Diseases Fujita Health University Toyoake Japan

14. The First Department of Internal Medicine School of Medicine, University of Occupational and Environmental Health Japan Kitakyushu Japan

15. Department of Medicine Rutgers Robert Wood Johnson Medical School and Institute for Health New Brunswick New Jersey USA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5263

Reference19 articles.

1. World Health Organization.International Agency for Research on Cancer. GLOBOCAN 2018: Estimated Cancer Incidence Mortality and Prevalence Worldwide in 2018. Japan factsheet2019.https://gco.iarc.fr/today/data/factsheets/populations/392-japan-fact-sheets.pdf.

2. Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs

3. A high positive predictive value algorithm using hospital administrative data identified incident cancer cases

4. A novel approach for medical research on lymphomas

5. Accuracy of lung cancer ICD-9-CM codes in Umbria, Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical research using real-world data: A narrative review;Respiratory Investigation;2024-11

2. Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication;Clinical Gastroenterology and Hepatology;2024-06

3. Development and Validation of Claims-based Algorithms for Identifying Hospitalized Patients With COVID-19 and Their Severity in 2020 and 2021;Journal of Epidemiology;2024

4. Validation of claims‐based algorithms for rheumatoid arthritis in Japan: Results from the VALIDATE‐J study;International Journal of Rheumatic Diseases;2023-12-31

5. Validity of claims-based diagnoses for infectious diseases common among immunocompromised patients in Japan;BMC Infectious Diseases;2023-10-03